We verified that miR-126 knockdown resulted in upregulation of SPRED1, PLK2, decreased p-ERK, p-MYC (S62), and MYC levels in primary inv(16) AML CD34+ cells (Fig. 5e and Supplementary Fig. 7f–g). Here, MYC is linked to acute myeloid leukemia.